Get the Stockscreener App
4.78
41.49%
-3.39
Aclarion Inc stock is traded at $4.78, with a volume of 2.38M.
It is down -41.49% in the last 24 hours and down -21.70% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$8.17
Open:
$5.88
24h Volume:
2.38M
Relative Volume:
2.81
Market Cap:
$3.21M
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.5259
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
-4.02%
1M Performance:
-21.70%
6M Performance:
-34.70%
1Y Performance:
+27.92%
1-Day Range:
$4.67
$5.96
1-Week Range:
$4.67
$9.36
52-Week Range:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
4.78 | 5.49M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
240.12 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
66.27 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.79 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.15 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.53 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Aclarion Inc Stock (ACON) Latest News
Healthcare Stocks To Keep An Eye On – January 8th - Defense World
How Aclarion Inc. stock reacts to global recession fearsJuly 2025 Intraday Action & Accurate Intraday Trade Tips - ulpravda.ru
Is the Market Bullish or Bearish on Aclarion Inc? - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Dow Edges Higher; US Economy Adds 50,000 Jobs In December - Benzinga
Aclarion Announces $10.4 Million Registered Direct Offering - TipRanks
Aclarion Signs Multiple Material Agreements - TradingView — Track All Markets
Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Aclarion, Inc., (ACON) stock: surges 39% as Nociscan adoption accelerates into 2026 - parameter.io
Aclarion Stock Climbs 50% After Strong 2025 Results And 2026 Outlook - Nasdaq
Aclarion Inc.: Analyzing the Sudden Surge - StocksToTrade
Is Aclarion Inc. Equity Warrant stock a safe haven assetPortfolio Risk Summary & Fast Moving Market Watchlists - ulpravda.ru
Will Aclarion Inc. stock reach all time highs in 2025Insider Buying & Entry Point Confirmation Signals - ulpravda.ru
Is Aclarion Inc. Equity Warrant stock overvalued by current metricsJuly 2025 Breakouts & Safe Entry Trade Signal Reports - ulpravda.ru
Aclarion Provides 2025 Update and 2026 Corporate Outlook - The Globe and Mail
Why Aclarion Inc. stock appeals to dividend seekers2025 Institutional Moves & Consistent Growth Equity Picks - ulpravda.ru
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
ACON Stock Pops 45% Pre-Market Today: What’s Driving The Move? - Asianet Newsable
Aclarion stock soars on 114% jump in Q4 Nociscan scan volumes By Investing.com - Investing.com South Africa
Aclarion stock soars on 114% jump in Q4 Nociscan scan volumes - Investing.com India
Why Is Aclarion Stock Skyrocketing Thursday?Aclarion (NASDAQ:ACON) - Benzinga
ACON Stock Price and Chart — NASDAQ:ACON - TradingView — Track All Markets
Why Is Aclarion Stock (ACON) Up Today? - TipRanks
Morning Market Movers: ACON, ASPC, IMRX, NVVE See Big Swings - RTTNews
Aclarion's 2025 Nociscan Scan Volumes Hit Record High, Shares Surge 45% - Nasdaq
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Aclarion Provides 2025 Update and 2026 Corporate Outlook - GlobeNewswire Inc.
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data - Ortho Spine News
Why Aclarion Inc. stock is seen as undervalued2026 world cup usa national team third place match key players possession football knockout prediction tactical review - ulpravda.ru
Aclarion says first patients enrolled at two additional CLARITY trial sites - TipRanks
Aclarion announces first patient enrollments at two additional Clarity trial sites - MarketScreener
Aclarion Advances Patient Enrollment in CLARITY Trial with Northwestern Medicine and Scripps Health Participation - Quiver Quantitative
AI spine scan study expands as hospitals test new back pain surgery guide - Stock Titan
Aclarion announces expansion plans with RadNet affiliates in NY, NJ - MSN
Aclarion (ACON) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Aclarion announces revised reverse stock split details - MSN
Aclarion (NASDAQ:ACON) Rating Increased to Hold at Wall Street Zen - Defense World
Aclarion, Inc. (NASDAQ:ACON) Sees Large Increase in Short Interest - Defense World
Aclarion announces publication of Nociscan article in pain issue of IJSS - MSN
What margin trends mean for Aclarion Inc. stock2025 Risk Factors & High Conviction Buy Zone Picks - Улправда
Is Aclarion Inc. stock a smart buy before Fed meeting2025 Fundamental Recap & Reliable Breakout Forecasts - Улправда
Is Aclarion Stock Built to Withstand a Pullback? - Trefis
Trading Action: Why Aclarion Inc. stock appeals to dividend seekersMarket Risk Report & Daily Growth Stock Investment Tips - Улправда
Is Aclarion Inc. stock cheap at current valuationPortfolio Value Summary & Growth-Oriented Investment Plans - Улправда
Retail Trends: Why Aclarion Inc. stock is seen as undervaluedShare Buyback & Community Consensus Picks - Улправда
Can Aclarion Inc. stock hit record highs again2025 Support & Resistance & Weekly Top Stock Performers List - Улправда
How Aclarion Inc. Equity Warrant stock benefits from global expansionGap Up & Long-Term Safe Investment Plans - Улправда
Will Aclarion Inc. Equity Warrant stock gain from strong economyEarnings Recap Summary & Community Trade Idea Sharing Platform - Улправда
Fund Flows: What margin trends mean for Aclarion Inc. stockMarket Performance Summary & Weekly Consistent Profit Watchlists - Улправда
Sell Signal: What margin trends mean for Aclarion Inc. stock2025 Trading Volume Trends & Weekly Hot Stock Watchlists - Улправда
Growth Value: What makes Aclarion Inc. (IT20) stock appealing to growth investorsWeekly Trade Review & Technical Analysis for Trade Confirmation - Улправда
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.07%
0.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):